Home
About Us
Science
- Technology
- Studies
Pipeline
Investors
- Fundraising
- Press Releases
Contact Us

Pipeline

Cairn Therapeutics’ lead candidate is CT-262. Cairn is also developing second generation products to improve various characteristics.

logo with white font

Copyright © 2024 Cairn Therapeutics | All right reserved.
Website design by SCD Consulting Services